The article discusses the slow adoption of endoscopic submucosal dissection (ESD) for the treatment of colorectal cancer in the United States, despite its potential to improve patient outcomes. ESD is a minimally invasive procedure that allows for the removal of large or complex colorectal lesions without the need for surgery.
Despite being widely used in Asia and Europe, ESD uptake in the US remains limited. The article highlights several factors contributing to this slow adoption, including limited training opportunities, technical challenges, and concerns over safety and reimbursement.